Recent Posts

• Amolyt Pharma Announces Appointment of Two Directors
• Lyon-based medtech MexBrain raises nearly €6 million from Arbevel, the French Tech Seed fund and Kreaxi for the clinical development of its medical device
• Theranexus : 2020 full-year results and update on the progress of main programs
• Flexitron Group, the Spanish group dedicated to IoT markets acquires majority stake in Webdyn SA to extend its footprint in the energy transition market.
• Amolyt Pharma Presents First Clinical Data for AZP-3601, its Parathyroid Hormone Analog for Hypoparathyroidism, at the Endocrine Society’s Virtual Annual Meeting (ENDO 2021)